CYTH
Price
$1.33
Change
-$0.01 (-0.74%)
Updated
Nov 28, 6:59 PM EST
103 days until earnings call
RDHL
Price
$2.79
Change
+$0.51 (+22.37%)
Updated
Nov 29, 10:01 AM EST
Ad is loading...

Compare predictions CYTH vs RDHL

Header iconCYTH vs RDHL Comparison
Open Charts CYTH vs RDHLBanner chart's image
Cyclo Therapeutics
Price$1.33
Change-$0.01 (-0.74%)
Volume$5.82K
CapitalizationN/A
Redhill Biopharma
Price$2.79
Change+$0.51 (+22.37%)
Volume$398.7K
CapitalizationN/A
View a ticker or compare two or three
CYTH vs RDHL Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CYTH vs. RDHL commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTH is a StrongBuy and RDHL is a StrongBuy.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (CYTH: $1.34 vs. RDHL: $2.28)
Brand notoriety: CYTH and RDHL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CYTH: 17% vs. RDHL: 1535%
Market capitalization -- CYTH: $30.74M vs. RDHL: $11.07M
CYTH [@Pharmaceuticals: Other] is valued at $30.74M. RDHL’s [@Pharmaceuticals: Other] market capitalization is $11.07M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $82.08B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTH’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • CYTH’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, RDHL is a better buy in the long-term than CYTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTH’s TA Score shows that 4 TA indicator(s) are bullish while RDHL’s TA Score has 6 bullish TA indicator(s).

  • CYTH’s TA Score: 4 bullish, 7 bearish.
  • RDHL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RDHL is a better buy in the short-term than CYTH.

Price Growth

CYTH (@Pharmaceuticals: Other) experienced а +8.06% price change this week, while RDHL (@Pharmaceuticals: Other) price change was +614.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.78%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was -7.20%.

Reported Earning Dates

CYTH is expected to report earnings on Mar 11, 2024.

RDHL is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+1.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for CYTH with price predictions.
OPEN
A.I.dvisor published
a Summary for RDHL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTH($30.7M) has a higher market cap than RDHL($11.1M). CYTH YTD gains are higher at: -5.634 vs. RDHL (-59.373). RDHL has higher annual earnings (EBITDA): 52.8M vs. CYTH (-19.36M). RDHL has more cash in the bank: 7.01M vs. CYTH (1.8M). CYTH has less debt than RDHL: CYTH (45.2K) vs RDHL (2.28M). RDHL has higher revenues than CYTH: RDHL (35.7M) vs CYTH (952K).
CYTHRDHLCYTH / RDHL
Capitalization30.7M11.1M277%
EBITDA-19.36M52.8M-37%
Gain YTD-5.634-59.3739%
P/E RatioN/AN/A-
Revenue952K35.7M3%
Total Cash1.8M7.01M26%
Total Debt45.2K2.28M2%
FUNDAMENTALS RATINGS
CYTH vs RDHL: Fundamental Ratings
CYTH
RDHL
OUTLOOK RATING
1..100
7642
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
46
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4134
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDHL's Valuation (46) in the Biotechnology industry is in the same range as CYTH (64) in the null industry. This means that RDHL’s stock grew similarly to CYTH’s over the last 12 months.

RDHL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CYTH (100) in the null industry. This means that RDHL’s stock grew similarly to CYTH’s over the last 12 months.

RDHL's SMR Rating (100) in the Biotechnology industry is in the same range as CYTH (100) in the null industry. This means that RDHL’s stock grew similarly to CYTH’s over the last 12 months.

RDHL's Price Growth Rating (34) in the Biotechnology industry is in the same range as CYTH (41) in the null industry. This means that RDHL’s stock grew similarly to CYTH’s over the last 12 months.

RDHL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CYTH (100) in the null industry. This means that RDHL’s stock grew similarly to CYTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTHRDHL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 6 days ago
84%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAU0.640.01
+1.33%
Galiano Gold
NTRS76.700.47
+0.62%
Northern Trust Corp
CNDT2.99-0.05
-1.64%
Conduent
MOD49.54-1.87
-3.64%
Modine Manufacturing Co
ICCT1.19-0.06
-4.80%
iCoreConnect

CYTH and

Correlation & Price change

A.I.dvisor tells us that CYTH and ACB have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYTH and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTH
1D Price
Change %
CYTH100%
-0.74%
ACB - CYTH
24%
Poorly correlated
-0.13%
RDHL - CYTH
24%
Poorly correlated
+128.00%
CGC - CYTH
22%
Poorly correlated
-1.26%
TEVA - CYTH
21%
Poorly correlated
-0.81%
PTPI - CYTH
21%
Poorly correlated
+1.57%
More